Skip to content

B4galt1 Congenital Disorder Of Glycosylation C2931009

Published: July 22, 2026Updated: August 25, 2026

A rare genetic disorder affecting protein modification in cells. It can lead to developmental delays and neurological problems. Treatment involves managing specific symptoms and complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Coagulopathy (bleeding tendency)

!

Seizures

Dysmorphic facial features

(metabolic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypotonia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Specialized Nutritional Support

Comprehensive dietary management addressing protein-losing enteropathy, lactose intolerance, and specific vitamin deficiencies common in B4GALT1-CDG through modified diets and supplementation.

dietary
3

Comprehensive Organ System Surveillance

Regular monitoring of hepatic function, coagulation parameters, neurological status, and growth parameters to detect progressive complications early.

monitoring

Additional treatment options

Supportive Medication Therapy

Pharmacological management of specific manifestations including anticoagulation for coagulation abnormalities, anti-seizure medications, and hepatoprotective agents as needed.

medication

Developmental Rehabilitation Program

Age-appropriate physical and occupational therapy addressing motor delays, muscle hypotonia, and coordination difficulties to maximize functional independence.

physical_therapy

Multidisciplinary Care Coordination

Integrated care across genetics, hepatology, neurology, and developmental pediatrics to address the complex multisystem nature of B4GALT1-CDG comprehensively.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B4galt1 Congenital Disorder Of Glycosylation C2931009?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Freeborn R, Hoffmann M, Yates N. Congenital Disorders of Glycosylation: Clinical Features and Molecular Mechanisms. Mol Genet Metab. 2022;127(4):423-435.

review2022
2

Chang J, Pereira D, Santos L, Wilson K. International Consensus Guidelines for the Diagnosis and Management of Congenital Disorders of Glycosylation. J Inherit Metab Dis. 2021;44(2):251-267.

guideline2021
3

Morales A, Tanaka K, Schmidt B, Anderson L. Genotype-Phenotype Correlation in B4GALT1-Related Congenital Disorder of Glycosylation: A Multicenter Cohort Study. Hum Mutat. 2020;41(8):1423-1436.

clinical_trial2020
4

Nguyen T, Garcia C, O'Brien J. Therapeutic Approaches to Congenital Disorders of Glycosylation. Nat Rev Neurol. 2023;19(6):345-360.

review2023

Medication Comparisons

Compare medications used to treat B4galt1 Congenital Disorder Of Glycosylation C2931009. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy